Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?

Bibliographic Details
Main Authors: Jennifer T. Lamberts, Patrik Brundin
Format: Article
Language:English
Published: Elsevier 2017-09-01
Series:Neurobiology of Disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996117301456
id doaj-1ff41ffe7b364ee5868981060b8a4774
record_format Article
spelling doaj-1ff41ffe7b364ee5868981060b8a47742021-03-22T12:45:37ZengElsevierNeurobiology of Disease1095-953X2017-09-01105271272Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?Jennifer T. Lamberts0Patrik Brundin1College of Pharmacy, Ferris State University, Big Rapids, MI, USACenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, MI, USAhttp://www.sciencedirect.com/science/article/pii/S0969996117301456
collection DOAJ
language English
format Article
sources DOAJ
author Jennifer T. Lamberts
Patrik Brundin
spellingShingle Jennifer T. Lamberts
Patrik Brundin
Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
Neurobiology of Disease
author_facet Jennifer T. Lamberts
Patrik Brundin
author_sort Jennifer T. Lamberts
title Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
title_short Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
title_full Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
title_fullStr Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
title_full_unstemmed Axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
title_sort axonal transport dysfunction in neurodegenerative diseases: the “holy grail” for developing disease modifying therapies?
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2017-09-01
url http://www.sciencedirect.com/science/article/pii/S0969996117301456
work_keys_str_mv AT jennifertlamberts axonaltransportdysfunctioninneurodegenerativediseasestheholygrailfordevelopingdiseasemodifyingtherapies
AT patrikbrundin axonaltransportdysfunctioninneurodegenerativediseasestheholygrailfordevelopingdiseasemodifyingtherapies
_version_ 1724207984206151680